A synthetic opioid is now officially a Schedule I drug, after a paperwork error
What happened
The Drug Enforcement Administration (DEA) corrected a clerical error that had left a synthetic opioid, 2-methyl AP-237, off the list of Schedule I controlled substances. This means the drug is now fully illegal to possess, manufacture, or distribute in the United States.
Why it matters
The DEA had already intended to make 2-methyl AP-237 a Schedule I drug, but a previous order accidentally invalidated the instructions. This correction closes that loophole. It ensures that law enforcement can prosecute cases involving this specific synthetic opioid, which is similar in effect to fentanyl.
The signal
Watch for any new enforcement actions or seizures of 2-methyl AP-237, which would indicate the correction has taken effect in practice.